Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million. Next quarter’s revenue ...
StockStory.org on MSN
3 Reasons EVH is Risky and 1 Stock to Buy Instead
Over the past six months, Evolent Health’s stock price fell to $8.92. Shareholders have lost 5.6% of their capital, which is disappointing considering the S&P 500 has climbed by 15.7%. This was partly ...
StockStory.org on MSN
Evolent Health (EVH) Stock Trades Up, Here Is Why
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 10.6% in the morning session after it agreed to sell its value-based primary care business, Evolent Care Partners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback